News

May 23, 2014 — AliveCor Inc. announced studies presented at the Heart Rhythm Society's (HRS) 35th annual scientific sessions expand the growing body of clinical information evaluating the use of the AliveCor heart monitor.

Home May 23, 2014
Home
Feature

May 23, 2014 — Medtronic announced the results from the first prospective randomized clinical trial to show that Medtronic implantable cardioverter-defibrillators (ICDs) can safely extend detection times before triggering therapy in secondary prevention patients. The results of the PainFree SST sub-study were unveiled as a late-breaking presentation at the Heart Rhythm Society's (HRS) 35th annual scientific sessions.

Home May 23, 2014
Home
genetic testing for coronary artery disease
Feature | Szilard Voros, M.D.

Improved understanding of the molecular mechanism of atherogenesis will help identify disease-related pathways and biomarkers that may also help to predict the future risk in asymptomatic individuals. Novel technologies, such as high-throughput sequencing have enabled scientists to gain better insights into diseases and disease progression.

Home May 22, 2014
Home
Technology

Extending the "Evolution of Visual Healthcare" to mobile devices, Agfa HealthCare launched its new Web-enabled mobile image management technology that brings the power of ICIS to iPhones, iPads, Web and Android mobile digital devices.

Home May 22, 2014
Home
ICD Implants Heart Rhythm Society Clinical Study Insurance Male
Feature

A study presented at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions, reports significant gender and health insurance disparities in implantable cardioverter defibrillator (ICD) procedures.

Home May 22, 2014
Home
News

Hospira Inc. issued a nationwide recall to the user level for one lot of Dobutamine Injection, USP, 250 mg, 20 mL, single-dose fliptop vial, (NDC 0409-2344-02), Lot 27-352-DK. (NDC and lot number can be found on the right-hand side of the primary label).

Home May 22, 2014
Home
Technology

May 21, 2014 — Siemens Healthcare announced that the U.S. Food and Drug Administration (FDA) cleared the Somatom Force computed tomography (CT) system — the next generation in dual source CT.

Home May 21, 2014
Home
Journal of Endovascular Therapy Hypertension Renal Denervation Therapy
Feature

Patients with hypertension after renal artery stenting who do not respond to drug treatment may have another option.

Home May 21, 2014
Home
News

May 21, 2014 — iRhythm Technologies Inc. announced that data from four studies presented at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions, support the use of the company's Zio Service to identify atrial fibrillation (AF) and other cardiac arrhythmias.

Home May 21, 2014
Home
3-d pronting, 3D printing
Feature

The FDA has recognized 3-D printing technology now exists to print medical devices and is gathering information regarding technical assessments that should be considered when it will inevitably begin reviewing these types of future FDA submissions.

Home May 20, 2014
Home
News

Sony Electronics’ Medical Systems Division showcased a full line of medical grade monitors for radiology applications, including the LMD-DM50, LMD-DM30C and LMD-DM30 models, at the 2014 Society for Imaging Informatics in Medicine (SIIM) meeting, in Long Beach, Calif.

Home May 20, 2014
Home
St. Jude Medical Portico TAVR System U.S. Implants Clinical Study
Feature

St. Jude Medical Inc. announced that the first patient implants occurred in the Portico Re-sheathable Transcatheter Aortic Valve System U.S. IDE Trial (PORTICO trial).

Home May 20, 2014
Home
Technology

May 20, 2014 — Siemens Healthcare announced the U.S. Food and Drug Administration (FDA) has cleared the 16- and 32-slice iterations of its Somatom Perspective computed tomography (CT) system.

Home May 20, 2014
Home
Feature

May 20, 2014 — GE Healthcare and Tesla Engineering Ltd. are collaborating to produce 7T human whole-body magnetic resonance imaging (MRI) scanners. The companies made the announcement at the joint meeting of the International Society for Magnetic Resonance in Medicine (ISMRM) and the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) in Milan.

Home May 20, 2014
Home
News

Transcatheter Technologies GmbH, an emerging medical device company that is developing a third-generation transcatheter aortic valve implantation (TAVI) system — Trinity) — announced that its founder and CEO, Wolfgang Goetz, M.D., Ph.D., will be meeting with potential investors, including potential corporate partners, at the EuroPCR annual scientific meeting in Paris, May 20-23.

Home May 20, 2014
Home
Subscribe Now